the "dear doctor" ad was aimed at generating patient requests to physicians, most of whom have the impression that Seldane is the least sedating antihistamine on the market. Clearly with antihistamines you lose if you snooze, unless you sell them as sleep aids.
A business bulletin in the Wall Street Journal stated that drug promotions are growing more aggressive, raising ethical questions. It gave as examples the Ayerst free air-fare plan already mentioned and the Merck launching of Mevocor (lovastatin), a new cholesterollowering drug. The article reported that Merck had offered cardiologists and their spouses all-expense-paid trips to a California resort to hear scientists discuss cholesterol research. According to the article, the editor of Medical Advertising News reports that many companies pay physicians $200 to attend a dinner and listen to a respected colleague praise a drug. 5 Actually, the expense-paid trips for specialists whose opinions and actions will make pr break a new specialty drug is not a particularly new practice, but the poor family doctors and general surgeons must be wondering when will they get their trips (how about Greyhound Ameripass?).
It is not surprising that high-powered, highly paid marketing staffs provide us with such innovation. They are paid to do it. Imagine the boredom of designing another cheap logo pen or pocket calendar with the product name glaring across the front. The guy I really admire was a hospital detailman taking the low road in Kentucky ten years ago. For every patient a surgeon would start on the company's new cephalosporin, a fifth of Chivas Regal was competently delivered. The pharmacy didn't even have to fudge the alcohol record for the annual hospital Christmas bash. I wonder if they offered the surgery patients a wee dram of Highland encouragement?
